LifeShield Atlanta Helps Lower Crime for City Residents

Greater Atlanta Area One of the Company's Hot Growth Areas

2013-06-02

ATLANTA, GA, June 02, 2013 (Press-News.org) Popular among Atlanta area renters and homeowners because of its completely wireless system and advanced technology, LifeShield Atlanta announced today that it has reached 10,000 customers and continues to show rapid growth.

According to SpotCrime for LifeShield Atlanta, the city has approximately 8,231 burglaries that occur every year.

"There has been a decrease in crime in Atlanta GA over the past ten years," said Evan Kramer, SVP, Interactive, LifeShield. "This is likely due to the fact that more and more residents are installing home security systems like LifeShield. The benefit to our system is we are completely wireless so there are no issues for renters drilling holes in walls to have a system installed. In fact, customers can take their system with them if they move and just reinstall it at the next place. It's extremely mobile."

LifeShield has security professionals and alert centers situated in small towns and cities all over the nation including Atlanta GA. With LifeShield, customers are protected with permanent monitoring 24 hours a day, seven days a week all year long. If there is an incident alarm, the operators will quickly get in touch with local Atlanta authorities and assistance will be immediately dispatched.

"For residents of Atlanta, GA, there is currently a 1 in 71 chance that you will become a victim of crime. Installing LifeShield and arming your system all the time whether you're at home or away from it will help to keep you safer," added Kramer.

For more home safety information and questions about LifeShield, call (877) 695-7210.

About LifeShield
LifeShield Security is the first national, professional grade and professionally monitored wireless security system that uses an easy to set-up "plug and protect" process, providing superior home protection and the best value in total home security.

For more on LifeShield Security, visit www.lifeshield.com.

ELSE PRESS RELEASES FROM THIS DATE:

Los Angeles Cosmetic Dentist, Dr. Ghasri, Offers Comprehensive Cosmetic Dental Treatments

2013-06-02

Beautiful smiles can boost confidence, improve feelings of self-worth, facilitate social interactions and even improve dental health. Los Angeles dentist, Dr. Poneh Ghasri, offers comprehensive cosmetic dental solutions to help her patients put their best smiles forward. When patients feel good about their smiles, they are more likely to maintain the dental habits that can help them preserve their dental health. Twice-daily brushing and flossing can be easier to perform, and regular dental checkups can keep teeth and gums their healthiest. Dr. Ghasri, Los Angeles cosmetic ...

Spectacular Party Dresses, Evening Dresses, Prom Dresses and Men's Suits from Offpricefashion.com

2013-06-02

At Offpricefashion.com we are now offering sensational party dresses, evening dresses and prom dresses. Our wholesale clothing store has wide selection of dresses comes with a price lower than other online stores out there. Our online store has been visited by customers and eventually proceeded to buying one for them or for their relatives, friend or for their loved ones. They saw the cheapest price and the high quality fabric that our dresses are made of. Famous fabric type such us silk, polyester, cotton and chiffon are what people want for their dresses. They want these ...

Tax Payers Unite and Say That Blue Tax's SUCKS Program is a Refreshing New Approach to Owing Taxes

2013-06-02

Never before has such an innovative and outside the box program been dreamed up by a boring tax company. Blue Tax has always been known for their creative, animated marketing approach in their commercial, print and radio advertisements. Love it or hate it, you remember it. Blue Tax has now gone over the top with their new tax program that they have entitled "SUCKS." An acronym for "So U Can Kick Start," the program identifies with tax payers who have found themselves in a debilitating tax situation. The program offers a free phone analysis to every delinquent ...

MGH-led studies shed new light on targeted lung cancer therapy

2013-06-01

Research teams led by Massachusetts General Hospital (MGH) Cancer Center investigators are publishing two important studies regarding use of the targeted cancer drug crizotinib for treatment of advanced lung cancer driven by specific genetic mutations. The first reports the final results of a global, phase 3 trial showing that crizotinib is superior to standard chemotherapy for treatment of advanced ALK-positive non-small cell lung cancer (NSCLC). The second paper describes the first report of resistance to crizotinib treatment in a patient with ROS1-positive NSCLC and ...

Spousal oral HPV, predictors of melanoma and throat cancer, preventing cancer readmissions

2013-06-01

Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology (ASCO) meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus (HPV) oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery. Highlights of Mount Sinai research at ASCO: Oral HPV Not Prevalent in Spouses of People with HPV-Positive Throat Cancer (Under Embargo Until 6:30 AM CDT on Saturday, June 1, 2013) In the first study of its ...

Targeted therapy boosts lung cancer outcomes

2013-06-01

BOSTON––Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber Cancer Institute researchers and a team of international collaborators. In a trial involving patients with non-small cell lung cancer (NSCLC) whose tumor cells harbored an abnormal ALK gene, those who received the oral drug crizotinib, which acts directly on ALK, went a median time of 7.7 months before their disease began to worsen, compared to 3 ...

New drug improves progression-free survival, shrinks tumors in rare cancer for first time

2013-06-01

CHICAGO, JUNE 1, 2013 — The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented on Saturday, June 1, at the 49th annual meeting of the American Society of Clinical Oncology (ASCO). The findings are potentially practice-changing for a historically "untreatable disease." Though uveal melanoma is rare — there are only 2,500 cases diagnosed in the United States each year — about half of patients will develop ...

No increased risk of infection for long-term sex partners of people with HPV-related oral cancers

2013-06-01

Spouses and long-term partners of patients with mouth and throat cancers related to infection with the human papilloma virus (HPV) appear to have no increased prevalence of oral HPV infections, according to results of a multicenter, pilot study led by Johns Hopkins investigators. The study's results suggest that long-term couples need not change their sexual practices, say the scientists. "While we can't guarantee that the partners of patients will not develop oral HPV infections or cancers, we can reassure them that our study found they had no increased prevalence of ...

Acidifying oceans could spell trouble for squid

2013-06-01

Acidifying oceans could dramatically impact the world's squid species, according to a new study led by Woods Hole Oceanographic Institution (WHOI) researchers and soon to be published in the journal PLOS ONE. Because squid are both ecologically and commercially important, that impact may have far-reaching effects on the ocean environment and coastal economies, the researchers report. "Squid are at the center of the ocean ecosystem—nearly all animals are eating or eaten by squid," says WHOI biologist T. Aran Mooney, a co-author of the study. "So if anything happens to ...

Procedures saving limbs of more peripheral arterial disease patients, Mayo Clinic finds

2013-06-01

SAN FRANCISCO -- Peripheral arterial disease is a common circulation problem in which reduced blood flow can lead to complications that jeopardize the limbs, possibly even requiring amputation. Procedures known as revascularization have reduced the need for amputations 40 percent over two decades, Mayo Clinic research shows. The findings were among several studies presented at the Society for Vascular Surgery annual meeting in San Francisco. In the amputation study, Mayo researchers analyzed patients in the Rochester Epidemiology Project, a National Institutes of ...

LifeShield Atlanta Helps Lower Crime for City Residents

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: